Patents Assigned to ELEVAI Labs, Inc.
  • Patent number: 11878038
    Abstract: An exosome-based skincare product containing exosomes excreted by lab cultured human umbilical mesenchymal stem cells within a solvent. Most frequently the solvent is a mixture of water and glycerin. Optional ingredients such as skin-conditioning agents, antioxidants, surfactants, buffering agents, viscosity decreasing agents, viscosity increasing agents, peptides, binders, and/or humectants may be included.
    Type: Grant
    Filed: July 14, 2022
    Date of Patent: January 23, 2024
    Assignee: Elevai Labs, Inc.
    Inventor: Jordan Robert Plews
  • Publication number: 20230172838
    Abstract: A method, and formulations for the method, for the treatment of hair loss is herein described. Typically, the method involves applying an exosome-based skincare product to skin affected by hair loss, such as the skin of the scalp. The exosome-based skincare product contains exosomes produced by and excreted from human umbilical mesenchymal stem cells cultured in vitro under specific conditions and then contained within a solvent. The hair loss may be caused by androgenic alopecia, alopecia areta, or telogen effulvium.
    Type: Application
    Filed: January 26, 2023
    Publication date: June 8, 2023
    Applicant: ELEVAI Labs, Inc.
    Inventor: Jordan Robert Plews
  • Publication number: 20230117663
    Abstract: An exosome-based skincare product containing exosomes excreted by lab cultured human umbilical mesenchymal stem cells within a solvent. Optional ingredients such as skin-conditioning agents, antioxidants, surfactants, buffering agents, viscosity decreasing agents, viscosity increasing agents, peptides, binders, and/or humectants may be included.
    Type: Application
    Filed: July 14, 2022
    Publication date: April 20, 2023
    Applicant: ELEVAI Labs, Inc.
    Inventor: Jordan Robert Plews